Jul 06, 2016 11:12 am UTC| Business
GENEVA, July 6, 2016 -- ObsEva, a Swiss biopharmaceutical company innovating women's reproductive health and pregnancy therapeutics, today announced that its Investigational New Drug (IND) application to the U.S. Food and...
Whipsaw Scores Silver at the Medical Design Excellence Awards (MDEA)
Jul 06, 2016 10:23 am UTC| Business
SAN JOSE, Calif., July 6, 2016 -- Whipsaw Inc, the Silicon Valley-based Industrial Design and Engineering firm that creates innovative products for companies around the globe, announces a silver MDEA award for the design...
Novolyze names Jena Roberts Vice President of Business Development
Jul 06, 2016 10:07 am UTC| Business
DIJON, France, July 6, 2016 -- Novolyze, a biotechnology company specializing in food safety, broadens its management team and hires Jena Roberts. Novolyze is recognized by the food industry for its innovation...
KOSC Telecom Selects ADVA FSP 3000 for 100G Connectivity Throughout France
Jul 06, 2016 07:09 am UTC| Business
PARIS, July 6, 2016 -- ADVA Optical Networking announced today that KOSC Telecom, France's newest telecommunications service provider, has selected the ADVA FSP 3000 for its nationwide DWDM transport network. The new...
Metso to publish its Interim Review for January-June 2016 on Thursday, July 21, 2016
Jul 06, 2016 07:05 am UTC| Business
HELSINKI, Finland, July 6, 2016 -- Metso Corporation's January-June Interim Review 2016 will be published on Thursday, July 21, 2016 at about 9:00 EEST (2:00 EST, 7:00 UTC, 8:00 CEST). After publication Interim Review is...
FRO - Grant of share options to members of the Board of Directors and management
Jul 06, 2016 06:24 am UTC| Business
Hamilton, Bermuda, July 6, 2016 -- Frontline Ltd. ("Frontline" or the "Company") hereby announces that 1,170,000 share options have been awarded to employees and board members in accordance with the terms of the Company's...
Umecrine Cognition appoints Dr. Bruce Scharschmidt to its board of directors
Jul 06, 2016 06:09 am UTC| Business
SOLNA, Sweden, July 6, 2016 -- Umecrine Cognition AB, a Karolinska Development (Nasdaq Stockholm: KDEV) portfolio company in clinical development with a novel treatment for hepatic encephalopathy (HE) in patients with...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects